Resultats globals: 4 registres trobats en 0.02 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
22 p, 4.3 MB Cerium oxide nanoparticles protect against oxidant injury and interfere with oxidative mediated kinase signaling in human-derived hepatocytes / Carvajal, Silvia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Perramón, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Casals, Gregori (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Oró, Denise (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ribera, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Morales Ruiz, Manuel (Universitat de Barcelona. Departament de Biomedicina) ; Casals, Eudald (Wuyi University. School of Biotechnology and Health Sciences) ; Casado, Pedro (Queen Mary University of London) ; Melgar Lesmes, Pedro (Universitat de Barcelona. Departament de Biomedicina) ; Fernández Varo, Guillermo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cutillas, Pedro (Queen Mary University of London) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia) ; Jiménez, Wladimiro (Universitat de Barcelona. Departament de Biomedicina)
Cerium oxide nanoparticles (CeO NPs) possess powerful antioxidant properties, thus emerging as a potential therapeutic tool in non-alcoholic fatty liver disease (NAFLD) progression, which is characterized by a high presence of reactive oxygen species (ROS). [...]
2019 - 10.3390/ijms20235959
International journal of molecular sciences, Vol. 20, Issue 23 (December 2019) , art. 5959  
2.
12 p, 4.4 MB Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats / Córdoba Jover, Bernat (Hospital Clínic i Provincial de Barcelona) ; Arce Cerezo, Altamira (Hospital Clínic i Provincial de Barcelona) ; Ribera, Jordi (Hospital Clínic i Provincial de Barcelona) ; Pauta, Montse (Hospital Clínic i Provincial de Barcelona) ; Oró, Denise (Hospital Clínic i Provincial de Barcelona) ; Casals, Gregori (Hospital Clínic i Provincial de Barcelona) ; Fernández Varo, Guillermo (Hospital Clínic i Provincial de Barcelona) ; Casals, Eudald (Institut Català de Nanociència i Nanotecnologia) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia) ; Jiménez, Wladimiro (Universitat de Barcelona. Departament de Biomedicina) ; Morales Ruiz, Manuel (Universitat de Barcelona. Departament de Biomedicina)
Background and aims: Cerium oxide nanoparticles are effective scavengers of reactive oxygen species and have been proposed as a treatment for oxidative stress-related diseases. Consequently, we aimed to investigate the effect of these nanoparticles on hepatic regeneration after liver injury by partial hepatectomy and acetaminophen overdose. [...]
2019 - 10.1186/s12951-019-0544-5
Journal of nanobiotechnology, Vol. 17 (October 2019) , art. 112  
3.
20 p, 2.6 MB Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease / Carvajal, Silvia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Perramón, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Oró, Denise (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Casals, Eudald (Wuyi University. School of Biotechnology and Health Sciences) ; Fernández Varo, Guillermo (Universitat de Barcelona. Departament de Biomedicina) ; Parra-Robert, Marina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; González de la Presa, Bernardino. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ribera, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Pastor, Óscar (Hospital Universitario Ramón y Cajal. Servicio de Bioquímica Clínica) ; Morales Ruiz, Manuel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia) ; Jiménez, Wladimiro (Universitat de Barcelona. Departament de Biomedicina)
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, ranging from steatosis to non-alcoholic steatohepatitis (NASH). Recently, cerium oxide nanoparticles (CeO₂NPs) have emerged as a new antioxidant agent with hepatoprotective properties in experimental liver disease. [...]
2019 - 10.1038/s41598-019-49262-2
Scientific reports (Nature Publishing Group), Vol. 9 (2019) , art. 12848  
4.
16 p, 3.0 MB Beyond the scavenging of reactive oxygen species (Ros) : direct effect of cerium oxide nanoparticles in reducing fatty acids content in an in vitro model of hepatocellular steatosis / Parra-Robert, Marina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Casals, Eudald (Wuyi University. School of Biotechnology and Health Sciences) ; Massana, Núria (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Zeng, Muling (Wuyi University. School of Biotechnology and Health Sciences) ; Perramón, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Fernández Varo, Guillermo (Universitat de Barcelona. Departament de Biomedicina) ; Morales Ruiz, Manuel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia) ; Jiménez, Wladimiro (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Casals, Gregori (Institut d'Investigacions Biomèdiques August Pi i Sunyer)
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic accumulation of lipids. Antisteatotic effects of cerium oxide nanoparticles (CeO₂NPs) have recently been shown in animal models of liver disease. [...]
2019 - 10.3390/biom9090425
Biomolecules, Vol. 9 , issue 9 (Sep. 2019) , art. 425  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.